
The American Society of Hematology published new guidelines on the treatment of immune thrombocytopenia (ITP), a rare blood disorder characterized by a decrease in the number of platelets. The guidelines were published in the journal Blood Advances and presented at ASH 2019 Annual Meeting and Exposition, in Orlando, Florida.
The guidelines, that gather all evidence for disease management in children and adults, were developed in partnership with the University of Oklahoma Health Sciences Center.







